Therefore, we speculated that Wenyang Huazhuo Tongluo Formula could downregulate vWF, VCAM-1, ICAM-1, and SELE by inhibiting the expression of HIF-1α, thereby alleviating SSc-induced pulmonary vascular injury. Here, HIF1A is linked to systemic sclerosis.